GB9614618D0 - Vaccine compositions - Google Patents
Vaccine compositionsInfo
- Publication number
- GB9614618D0 GB9614618D0 GBGB9614618.8A GB9614618A GB9614618D0 GB 9614618 D0 GB9614618 D0 GB 9614618D0 GB 9614618 A GB9614618 A GB 9614618A GB 9614618 D0 GB9614618 D0 GB 9614618D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine compositions
- vaccine
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/42—Salmonella
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9614618.8A GB9614618D0 (en) | 1996-07-11 | 1996-07-11 | Vaccine compositions |
EP97930649A EP0938565A2 (en) | 1996-07-11 | 1997-07-08 | Vaccine compositions |
PCT/GB1997/001837 WO1998002552A2 (en) | 1996-07-11 | 1997-07-08 | Vaccine compositions |
AU34529/97A AU3452997A (en) | 1996-07-11 | 1997-07-08 | Vaccine compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9614618.8A GB9614618D0 (en) | 1996-07-11 | 1996-07-11 | Vaccine compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9614618D0 true GB9614618D0 (en) | 1996-09-04 |
Family
ID=10796768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9614618.8A Pending GB9614618D0 (en) | 1996-07-11 | 1996-07-11 | Vaccine compositions |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0938565A2 (en) |
AU (1) | AU3452997A (en) |
GB (1) | GB9614618D0 (en) |
WO (1) | WO1998002552A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026155B2 (en) | 1999-02-02 | 2006-04-11 | Regents Of The University Of California | Method of reducing bacterial proliferation |
CN1639339B (en) | 2002-02-27 | 2011-10-05 | Dsmip资产有限公司 | Fermentation process |
FR2862068B1 (en) * | 2003-11-06 | 2007-10-12 | Metabolic Explorer Sa | OPTIMIZED MICROORGANISM STRAINS FOR NADPH CONSUMPTION BIOSYNTHESIS PATHWAYS |
-
1996
- 1996-07-11 GB GBGB9614618.8A patent/GB9614618D0/en active Pending
-
1997
- 1997-07-08 WO PCT/GB1997/001837 patent/WO1998002552A2/en not_active Application Discontinuation
- 1997-07-08 AU AU34529/97A patent/AU3452997A/en not_active Abandoned
- 1997-07-08 EP EP97930649A patent/EP0938565A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO1998002552A2 (en) | 1998-01-22 |
AU3452997A (en) | 1998-02-09 |
EP0938565A2 (en) | 1999-09-01 |
WO1998002552A3 (en) | 1998-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA978868B (en) | Vaccine composition | |
IL118004A0 (en) | Vaccine compositions | |
GB9503863D0 (en) | Vaccine compositions | |
GB9600426D0 (en) | Compositions | |
IL137999A0 (en) | Vaccine compositions | |
PL332118A1 (en) | Remineralisable compositions | |
IL128718A0 (en) | Naaldase compositions | |
IL130330A0 (en) | Endo-ectoparasiticidal compositions | |
PL331424A1 (en) | Antipaludian vaccine composition | |
GB9623233D0 (en) | Vaccine composition | |
HU9600207D0 (en) | Vaccine compositions | |
GB9624540D0 (en) | Compositions | |
GB9623562D0 (en) | Sachet-packaged compositions | |
GB9620504D0 (en) | Compositions | |
HRP970569A2 (en) | Fharmaceutical compositions | |
GB9614618D0 (en) | Vaccine compositions | |
GB9620503D0 (en) | Compositions | |
GB9611365D0 (en) | Compositions | |
GB9600545D0 (en) | Compositions | |
GB9622437D0 (en) | Vaccine composition | |
GB9622438D0 (en) | Vaccine composition | |
GB9622439D0 (en) | Vaccine composition | |
GB9601739D0 (en) | Vaccine Compositions | |
GB9403417D0 (en) | Vaccine compositions | |
GB9416097D0 (en) | Vaccine compositions |